Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BrainValue Neurotech
Tel Aviv, Tel Aviv District, Israellinkedin.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
BrainValue Neurotech is an Israeli deep tech startup developing the world’s first emotional brain-computer interface ("eBCI") to enable precision treatment for severe PTSD. The company leverages proprietary technology licensed from the Weizmann Institute, aiming to map and modulate emotional neural circuits non-invasively. As of mid-2025, it remains at preclinical/prototype stage with no published clinical results.
- Therapeutic areas
- Psychiatry
- Modalities
- DeviceDigital therapeutic
- Industry
- Digital Health Medical Devices
02
Partnerships
Technology licensing partnership with Weizmann Institute.
Beyond the preview
Go deeper on BrainValue Neurotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BrainValue Neurotech.